September 23, 2016
Takeda Pharmaceutical said on September 21 that it has sealed a partnership with India’s Zydus Cadila to accelerate the development of a chikungunya vaccine being developed by US biotech Inviragen, which was acquired by the Japanese giant in 2013 ...read more